Vitalhub (TSE:VHI) Director Sells C$258,000.00 in Stock

Key Points

• Vitalhub Corp. Director Steve Garrington sold 20,000 shares at an average price of C$12.90, equating to a total value of C$258,000, resulting in a 25% decrease in his ownership.
• The company's stock is currently trading at C$11.54, reflecting a small decline of 0.5%, with a market capitalization of C$725.06 million.
• Several analysts have recently increased their target prices for Vitalhub shares, with reports ranging from C$15.00 to C$16.00, indicating positive sentiment towards the stock.

Vitalhub Corp. (TSE:VHI - Get Free Report) Director Steve Garrington sold 20,000 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of C$12.90, for a total value of C$258,000.00. Following the completion of the sale, the director owned 60,000 shares of the company's stock, valued at C$774,000. This trade represents a 25.00% decrease in their ownership of the stock.

Vitalhub Trading Down 0.9%

Vitalhub stock traded down C$0.10 during mid-day trading on Friday, reaching C$11.09. The company's stock had a trading volume of 134,896 shares, compared to its average volume of 151,120. Vitalhub Corp. has a twelve month low of C$8.30 and a twelve month high of C$14.64. The business has a 50 day moving average price of C$12.67 and a 200-day moving average price of C$11.06. The firm has a market cap of C$696.78 million, a price-to-earnings ratio of 138.63, a PEG ratio of 1.18 and a beta of 0.93.

Analysts Set New Price Targets

A number of brokerages recently weighed in on VHI. National Bankshares set a C$16.00 price objective on shares of Vitalhub and gave the company an "outperform" rating in a research report on Thursday, August 21st. National Bank Financial upgraded Vitalhub to a "strong-buy" rating in a research note on Monday, June 9th. TD Securities upped their target price on Vitalhub from C$15.00 to C$16.00 and gave the company a "buy" rating in a report on Monday, August 11th. Raymond James Financial raised their price target on Vitalhub from C$14.50 to C$15.00 and gave the stock an "outperform" rating in a report on Tuesday, August 12th. Finally, Scotiabank upped their price objective on Vitalhub from C$14.00 to C$14.50 and gave the stock an "outperform" rating in a research note on Friday, June 20th. One equities research analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Buy" and an average price target of C$14.08.

Vitalhub Company Profile

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.